Byetta Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Alerts
• Clinical Trials

SR-Exenatide (PT320) to Eveluate Efficacy and Safety in Patients With Early Parkinson's Disease
Condition:   Early Parkinson's Disease Interventions:   Drug: PT320 2.0mg Placebo;   Drug: PT320 2.0 mg;   Drug: PT320 2.5 mg Sponsor:   Peptron, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 17, 2020 Category: Research Source Type: clinical trials

Exenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson's Disease
Condition:   Parkinson's Disease Intervention:   Drug: Exenatide extended release 2mg subcutaneous injection (Bydureon) Sponsor:   University College, London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2020 Category: Research Source Type: clinical trials